BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20350126)

  • 1. Advances in pharmacogenomics technologies.
    Bhasker CR; Hardiman G
    Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarrays in pharmacogenomics--advances and future promise.
    Chicurel ME; Dalma-Weiszhausz DD
    Pharmacogenomics; 2002 Sep; 3(5):589-601. PubMed ID: 12223046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.
    Yengi LG
    Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-high-throughput sequencing, microarray-based genomic selection and pharmacogenomics.
    Hardiman G
    Pharmacogenomics; 2008 Jan; 9(1):5-9. PubMed ID: 18154443
    [No Abstract]   [Full Text] [Related]  

  • 6. Integration of genomic technologies for accelerated cancer drug development.
    Basik M; Mousses S; Trent J
    Biotechniques; 2003 Sep; 35(3):580-2, 584, 586 passim. PubMed ID: 14513563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BeadArray-based solutions for enabling the promise of pharmacogenomics.
    Fan JB; Hu S; Craumer W; Barker D
    Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA microarray technology and antimicrobial drug discovery.
    Ivanov I; Schaab C; Planitzer S; Teichmann U; Machl A; Theml S; Meier-Ewert S; Seizinger B; Loferer H
    Pharmacogenomics; 2000 May; 1(2):169-78. PubMed ID: 11256588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in anticoagulant drug development.
    Iqbal O
    Pharmacogenomics; 2002 Nov; 3(6):823-8. PubMed ID: 12437483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA microarrays and pharmacogenomics.
    Meloni R; Khalfallah O; Biguet NF
    Pharmacol Res; 2004 Apr; 49(4):303-8. PubMed ID: 15202510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.
    Vizirianakis IS
    Eur J Pharm Sci; 2002 Apr; 15(3):243-50. PubMed ID: 11923056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing false positive findings in statistical analysis of pharmacogenomic biomarker studies using high-throughput technologies.
    Matsui S
    Curr Drug Saf; 2006 May; 1(2):135-41. PubMed ID: 18690924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic biomarkers: new tools in current and future drug therapy.
    Sim SC; Ingelman-Sundberg M
    Trends Pharmacol Sci; 2011 Feb; 32(2):72-81. PubMed ID: 21185092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.